Iron Bisglycinate vs Ferrous Sulfate: Which Is Better?

Creator: Superpower
Published: 2026-04-04

Understand what your iron supplements results really mean

See your biomarkers in context with a comprehensive panel.

CLIA-certified labs
HIPAA compliant
Personalized health protocol

Is iron bisglycinate better than ferrous sulfate?

Iron bisglycinate is better tolerated than ferrous sulfate, and the two repair iron stores by comparable amounts. Trial evidence on repletion is mixed, so neither form wins on ferritin alone. If ferrous sulfate sits well with you, it does the job for less money. If it upsets your stomach, bisglycinate is the form you are more likely to keep taking.

	Ferrous sulfate	Iron bisglycinate
Absorption pathway	DMT-1 (ionic iron)	DMT-1, after joining the nonheme-iron pool
Elemental iron per typical tablet	65 mg per 325 mg tablet	Varies by product; 25 mg daily in a pregnancy trial
GI side-effect rate	25-75% of users, depending on dose and preparation	Lower; about a third as many GI complaints as other iron forms in pregnancy trials
Food interaction	Calcium, polyphenols, and phytates reduce absorption	Chelation protects against these inhibitors, so it can be taken with meals
Cost	Low; generics widely available	Typically 3-5x more for equivalent elemental iron
Best for	People who tolerate iron and want the lowest cost	People with GI sensitivity, vegetarians, people who take iron with meals, and older adults or proton pump inhibitor users with low stomach acid

Both forms are absorbed through the same intestinal pathway, and the differences come from what happens to each iron form before and during that step.

How iron absorption works

Most dietary iron is in the ferric (Fe3+) state, which must be reduced to the ferrous (Fe2+) state by duodenal brush border enzymes before it can be absorbed via the divalent metal transporter 1 (DMT-1) in the proximal small intestine. This reduction step is enhanced by an acidic gastric environment and by reducing agents such as vitamin C.

Heme iron (from animal products) uses a separate, more efficient transporter and is absorbed at approximately two to three times the rate of non-heme iron. Ferrous sulfate and iron bisglycinate are both non-heme iron forms but use partially different absorption mechanisms, which accounts for their differing tolerability and efficacy profiles.

Ferrous sulfate: The standard option

How it works

Ferrous sulfate provides iron in the Fe2+ form, which is directly ready for absorption via DMT-1. It is highly soluble in gastric acid, releasing iron rapidly in the stomach and proximal duodenum. This rapid release is effective for absorption but also means that a significant proportion of the dose encounters the gastric mucosa as free ionic iron, which is reactive and irritating.

Efficacy

Ferrous sulfate has a long evidence base and is the reference standard against which other iron forms are compared. It effectively raises serum ferritin and hemoglobin when taken at therapeutic doses in confirmed iron-deficient individuals. Standard therapeutic doses typically range from 60 to 200 mg of elemental iron per day, though lower doses (40 to 80 mg elemental) taken every other day have been shown in recent research to achieve comparable ferritin repletion with better tolerability. Dose specifics should be determined by a provider based on the severity of deficiency.

Limitations

The principal limitation is tolerability. Constipation, nausea, and epigastric pain are common and are the leading causes of non-adherence. Ferrous sulfate also significantly inhibits the absorption of several medications (thyroid hormone, fluoroquinolone antibiotics, tetracyclines) and should be taken two hours apart from these when co-prescribed.

Iron bisglycinate: The chelated alternative

How it works

Iron bisglycinate is a chelated form of iron in which ferrous iron is bound to two glycine molecules. This chelation protects the iron from forming poorly absorbed complexes with dietary inhibitors (phytates, polyphenols, calcium) in the gut lumen. Once it reaches the stomach or duodenum, though, its iron becomes part of the nonheme-iron pool and is absorbed the same way as iron from ferrous sulfate.

Efficacy

Trial results on repletion are mixed. In pooled randomized trials, bisglycinate raised hemoglobin more than other iron forms in pregnant women. Its edge on ferritin did not reach significance, and children showed no difference in either marker. A key advantage is that chelated iron is less affected by dietary inhibitors.

Tolerability

Bisglycinate's better tolerability translates into substantially better adherence in clinical settings, which is clinically meaningful: a supplement that is tolerated and taken consistently is more effective than a theoretically superior supplement that is discontinued due to side effects.

Test 100+ biomarkers

One blood draw. A full picture of your health, explained in plain language.

Book your test

Test 100+ biomarkers

One blood draw. A full picture of your health, explained in plain language.

Book your test

Which biomarkers should you test before and during iron supplementation?

Iron supplementation should be guided by laboratory confirmation of deficiency and monitored to assess response and avoid excess. The key markers:

Ferritin — iron storage; most sensitive marker for depletion; primary target for repletion monitoring
Hemoglobin — Oxygen-carrying capacity; falls later than ferritin in iron deficiency
MCV (Mean corpuscular volume) — red cell size; microcytic pattern in iron deficiency anemia
Iron saturation + TIBC — Transport capacity; low saturation with high TIBC is classic iron deficiency pattern

Superpower's Baseline Blood Panel includes ferritin, hemoglobin, MCV, serum iron, iron saturation, and TIBC, providing the complete picture needed to confirm iron deficiency, characterize its severity, and monitor response to supplementation. Testing before starting supplementation and again after 8 to 12 weeks provides the data needed to assess whether the chosen form and dose are effective.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your health routine. Superpower offers blood panels that include the biomarkers discussed in this article. Links to individual tests are provided for informational context.

Frequently Asked Questions

In comparative trials, iron bisglycinate raised hemoglobin more than other iron forms in pregnant women, but its ferritin gains were not significantly higher, and children showed no difference in either marker. The chelation protects against dietary inhibitors that reduce ferrous sulfate absorption, which is a meaningful advantage in real-world conditions where supplements are taken near meals. Whether it is "better absorbed" in a strict mechanistic sense depends on the experimental conditions, but clinically the two forms perform similarly on iron stores.

Free ionic iron in the intestinal lumen reacts with gut microbiota and intestinal cells, alters bowel motility, and the unabsorbed fraction contributes to the formation of harder stools. The oxidative stress produced by free iron in the gut also disrupts the intestinal mucosa. These effects are dose-dependent. Lower doses, every-other-day dosing, and taking ferrous sulfate with food (which reduces absorption but also reduces mucosal exposure) can mitigate these effects, though food also reduces absorption.

Yes. Switching is straightforward, but the elemental iron content of each product should be compared. Ferrous sulfate tablets typically contain 65 mg of elemental iron per 325 mg tablet. Iron bisglycinate products vary widely in elemental iron content. So a 25 mg bisglycinate dose is not equal to a 325 mg ferrous sulfate tablet on paper, since that tablet carries 65 mg of elemental iron. Still, in one pregnancy trial, 25 mg of bisglycinate iron daily prevented iron deficiency about as well as 50 mg of ferrous sulfate iron, with fewer stomach complaints. That trial tested prevention, not treatment of an existing deficiency. The key number for dosing is elemental iron, not the total weight of the supplement compound. Your provider can advise on an equivalent dose when switching.

Meaningful increases in ferritin typically require 8 to 12 weeks of consistent supplementation at adequate doses in confirmed iron-deficient individuals. Hemoglobin may begin to improve within 4 to 6 weeks. Ferritin repletion to target levels can take several months depending on the degree of initial depletion and the rate of ongoing loss (e.g., menstrual blood loss). Repeat testing at 8 to 12 weeks provides a meaningful data point for assessing response.

That depends on your tolerance of standard iron forms. If you take ferrous sulfate without significant side effects, the additional cost of bisglycinate provides minimal clinical benefit — both achieve comparable ferritin repletion. However, if ferrous sulfate causes constipation, nausea, or cramping severe enough to affect adherence, bisglycinate's improved tolerability can be the difference between a supplement you actually take consistently and one you abandon. Consistent dosing over months matters more than theoretical absorption advantages.

Yes. One of the practical advantages of iron bisglycinate over ferrous sulfate is that its chelated structure partly shields the iron from phytates in food, though tea and espresso still cut its absorption. This means bisglycinate can be taken with meals with a smaller absorption penalty than ferrous sulfate. For people who cannot tolerate iron on an empty stomach, this flexibility is a meaningful benefit that may improve overall absorption through better adherence.

Iron bisglycinate is often the more practical choice for vegetarians. Plant-based diets tend to be high in phytates and polyphenols (from whole grains, legumes, tea, and coffee), which are potent inhibitors of standard iron absorption via DMT-1. Because bisglycinate's chelated structure protects the iron from these inhibitors, it maintains better absorption in the context of a vegetarian dietary pattern. Vegetarians also tend to need supplementation more frequently due to the absence of highly bioavailable heme iron from animal sources.

Absolutely. Testing is the essential first step — not just for choosing a form, but for determining whether supplementation is appropriate at all. Ferritin, serum iron, transferrin saturation, and TIBC together characterize the type and severity of any deficiency. Supplementing iron without confirmed deficiency carries risks including organ iron accumulation, particularly in individuals with undiagnosed hemochromatosis. A baseline panel also gives you a reference point against which to measure whether your chosen supplement and dose are actually working.